ClinicalTrials.Veeva

Menu

Evaluation of the Variation of the Sub-pulmonary Velocity-time Integral to Predict Fluid Responsiveness

H

Hospital Nord

Status

Enrolling

Conditions

Fluid Responsiveness Predictability
Fluid Resuscitation

Treatments

Drug: Fluid bolus administration

Study type

Observational

Funder types

Other

Identifiers

NCT07202637
ITV-VD
2023-A02636-39 (Other Identifier)

Details and patient eligibility

About

Fluid administration is the first-line treatment in hypovolemic states in critically ill patients. Prediction of fluid responsiveness is possible with echocardiography by assessing the variation of the sub-aortic velocity-time integral (AoVTI) during a passive leg raising test (PLR) or Mini-fluid challenge. However, VTI-Ao measurement is not feasible in all patients due to poor echogenicity. Validation of new fluid-responsiveness indices may facilitate the evaluation in this patient population. Among the available indices, variation of the sub-pulmonary VTI is a potential criterion.

Enrollment

205 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with measurable sub-pulmonary VTI in at least one of the two windows: parasternal short-axis or subcostal.
  • Patient with measurable sub-aortic VTI in apical 4-chamber view before and after PLR maneuver.
  • Patient with suspected hypovolemia or whose hemodynamic status justifies vasopressor infusion.

Exclusion criteria

  • Severe left ventricular dysfunction defined by left ventricular ejection fraction (LVEF) < 30%.
  • Severe right ventricular dysfunction defined by TAPSE < 12 mm.
  • Cardiac arrhythmia or atrial fibrillation.
  • Abdominal compartment syndrome.
  • Amputation of one or both lower limbs.
  • Intracranial hypertension.
  • Pregnant women (ruled out by systematic pregnancy test at ICU admission).
  • Minors.

Trial design

205 participants in 1 patient group

Patients suspected of hypovolemia
Description:
Patients with suspected hypovolemia who need to be evaluated for fluid responsiveness
Treatment:
Drug: Fluid bolus administration

Trial contacts and locations

2

Loading...

Central trial contact

Gary DUCLOS, MD, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems